Non-alcoholic fatty liver disease and diabetes.

Non-alcoholic fatty liver disease and diabetes.

Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2DM) are common conditions that regularly co-exist and can act synergistically to drive adverse outcomes. The presence of both NAFLD and T2DM increases the likelihood of the development of complications of diabetes (including both macro...

Bibliografske podrobnosti
Main Authors:	Hazlehurst, J, Woods, C, Marjot, T, Cobbold, J, Tomlinson, J
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 2016

Podobne knjige/članki

Glucocorticoids and non-alcoholic fatty liver disease.
od: Woods, C, et al.
Izdano: (2015)

Non-alcoholic fatty liver disease in common endocrine disorders.
od: Hazlehurst, J, et al.
Izdano: (2013)

Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management
od: Marjot, T, et al.
Izdano: (2019)

Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital
od: Marjot, T, et al.
Izdano: (2017)

Non-alcoholic fatty liver disease
od: Pavlides, M, et al.
Izdano: (2019)

Pathogenesis of non-alcoholic fatty liver disease.
od: Dowman, J, et al.
Izdano: (2010)

The diagnosis of non-alcoholic fatty liver disease: authors' reply
od: Dowman, J, et al.
Izdano: (2012)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
od: Dowman, J, et al.
Izdano: (2011)

Current therapeutic strategies in non-alcoholic fatty liver disease.
od: Dowman, J, et al.
Izdano: (2011)

Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management.
od: Armstrong, M, et al.
Izdano: (2014)

Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alstrom syndrome.
od: Gathercole, L, et al.
Izdano: (2016)

Non-alcoholic fatty liver disease in obese persons with diabetes
od: Tomašević Ratko, et al.
Izdano: (2007-01-01)

Non-alcoholic fatty liver disease and diabetic retinopathy: Is there an association?
od: Mathew Jacob, et al.
Izdano: (2023-09-01)

Non-Alcoholic Fatty Liver Disease: The Silent Epidemic
od: J. M. R. P. Bandara
Izdano: (2024-04-01)

Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey
od: Sheridan, D, et al.
Izdano: (2017)

NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
od: L.V. Chistova, et al.
Izdano: (2010-11-01)

Curcumin and non-alcoholic fatty liver disease
od: Nasrin Sharifi, et al.
Izdano: (2024-06-01)

NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
od: L.V. Chistova, et al.
Izdano: (2010-11-01)

Multi-parametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
od: Pavlides, M, et al.
Izdano: (2017)

Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
od: Marium Ahmed, et al.
Izdano: (2024-04-01)

Trend of Non-Alcoholic Fatty Liver Disease in Type II Diabetes Mellitus
od: Fariha Khan, et al.
Izdano: (2024-05-01)

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
od: Preya J. Patel, et al.
Izdano: (2017-01-01)

Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome
od: Moolla, A, et al.
Izdano: (2020)

Arterial stiffness in non-alcoholic fatty liver disease
od: T.V. Chendey, et al.
Izdano: (2024-06-01)

Gut microbiome in non-alcoholic fatty liver disease
od: Anastasios Mpountouridis, et al.
Izdano: (2025-01-01)

Genetic Aspects of Non-Alcoholic Fatty Liver Disease
od: Pavel O. Bogomolov, et al.
Izdano: (2019-01-01)

Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
od: Saira Rafaqat, et al.
Izdano: (2024-03-01)

Non-alcoholic fatty liver disease and cognitive impairment
od: Elena V. Onuchina, et al.
Izdano: (2024-12-01)

Improvement of non-alcoholic fatty liver disease treatment
od: P. I. Seliverstov, et al.
Izdano: (2014-10-01)

New aspects of non-alcoholic fatty liver disease
od: V. V. Tsukanov, et al.
Izdano: (2015-09-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
od: D. V. Blinov
Izdano: (2015-12-01)

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
od: A. E. Bagriy, et al.
Izdano: (2021-06-01)

Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease
od: Sonal Kumar, et al.
Izdano: (2024-04-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
od: M. V. Mayevskaya, et al.
Izdano: (2018-11-01)

A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease
od: Ahmed, A, et al.
Izdano: (2012)

Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
od: Samar A. Zailaie, et al.
Izdano: (2024-01-01)

Shift work and evening chronotype are associated with hepatic fat fraction and non-alcoholic fatty liver disease in 282,303 UK biobank participants
od: Robert Maidstone, et al.
Izdano: (2024-01-01)

Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia
od: Masahiro Kikuchi, et al.
Izdano: (2024-09-01)

Association between toothbrushing and non-alcoholic fatty liver disease.
od: Ji-Youn Kim, et al.
Izdano: (2021-01-01)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
od: Evgenia Pavlovna Kosobyan, et al.
Izdano: (2010-03-01)